Oncocontraception

Ashlesha Patel*, Alicia Roston, Kelly Stempinski, Lindsay Zimmerman, Erica O’Neill, Ashok R. Patel

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Over 700,000 women in the United States are diagnosed with cancer each year. Nearly 17 % of women with cancer are within the reproductive age. With improvements in treatments and prognosis, quality of life factors are increasing in importance for these women. Reproductive health is an important quality of life indicator. Focus on oncofertility has overshadowed other aspects of reproductive health including sexuality and oncocontraception. In this chapter we focus on the multiple facets of oncocontraception. While cancer treatments may alter fertility significantly, in the absence of reliable markers of fertility, contraception is paramount to reduce the risk of an unintended pregnancy. Cancer survivors are less likely to be offered effective contraception, if offered at all. Models of conceptualizing contraception are outlined as well as strategies to implement oncocontraception within oncologic care.

Original languageEnglish (US)
Title of host publicationContraception for the Medically Challenging Patient
PublisherSpringer New York
Pages255-271
Number of pages17
ISBN (Electronic)9781493912339
ISBN (Print)9781493912322
DOIs
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Health Professions(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Oncocontraception'. Together they form a unique fingerprint.

Cite this